You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 104 No. 6, DECEMBER 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Current Clinical Status of Lipid-Mobilizer Hormone

CHRIS J. D. ZARAFONETIS, M.D.; JOSEPH SEIFTER, M.D.; DAVID H. BAEDER, Ph.D.; JOHN P. KALAS, M.D.

AMA Arch Intern Med. 1959;104(6):974-981.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A number of studies dealing with a lipidmobilizing hormone (LM) have been reported from these experimental and clinical laboratories.1-18 This substance was discovered, in 1954, by Seifter and Baeder.1 These investigators, working with rats and dogs, demonstrated a lipemia-clearing effect with hyaluronidase, with hyaluronate, and with deoxycorticosterone. At the same time, they found that the lipemia-clearing effect of these substances could be inhibited by the administration of cortisone or by stress (cold exposure) and by nephrosis. Studies in connection with the latter findings led to the discovery of LM in the plasma of several animal species, including man.2 Other experiments by Seifter and Baeder revealed that the pituitary was essential for the release of LM.3 More recently, LM was recovered from the posterior pituitary of hogs,4 denoting that this hormone is either produced or stored at that site. LM is dialyzable; it has been crystallized and appears to be . . . [Full Text PDF of this Article]


Author Affiliations

Philadelphia; Radnor, Pa.; Philadelphia

From the Department of Medicine, Temple University School of Medicine, Philadelphia, and the Wyeth Institute for Medical Research, Radnor, Pa.; Professor of Clinical and Research Medicine (Dr. Zarafonetis); Director, Wyeth Institute for Medical Research (Dr. Seifter); Pharmacologist, Wyeth Institute for Medical Research (Dr. Baeder), and Research Fellow in Medicine (Dr. Kalas).


Footnotes

Received for publication July 6, 1959.

Read before the Section on Internal Medicine at the 108th Annual Meeting of the American Medical Association, Atlantic City, June 11, 1959.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.